Establishment Labs unveils product extensions, presents breast tissue preservation data

Establishment Labs flagged new clinical and scientific breast tissue preservation data already presented at the 11th World Symposium on Ergonomic Implants. Findings supported the rationale for its minimally invasive platform, citing early- and mid-term clinical experience, including initial published U.S. multicenter use. Management pointed to market momentum, citing 11% growth in U.S. breast augmentation procedures, to frame demand for its approach. Product launch plan broadened Mia and Preservé with new sizes and tools, aimed at expanding the addressable patient pool. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via (Ref. ID: 202609210800BIZWIRE_USPR_____20260921_BW384771) on September 21, 2026, and is solely responsible for the information contained therein. (C)